Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fort Worth, Texas 76134


Purpose:

The purpose of this study to assess the safety and IOP-lowering efficacy of changing to Duo-Travatan from prior Timolol 0.5% monotherapy in uncontrolled patients with open-angle glaucoma or ocular hypertension.


Criteria:

Inclusion Criteria: - Clinical diagnosis of ocular hypertension - Primary open-angle or pigment dispersion glaucoma in both eyes - IOP of between 19 to 35 mmHg (at any time of the day) in at least one eye (which would be designated as the study eye) - Wiliness to discontinue the use of all other ocular hypotensive medication(s) prior to receiving the study medication for the entire course of the study Exclusion Criteria: - Known medical history of allergy, hypersensitivity or poor tolerance to any component of Duo-Travatan® that is deemed clinically significant in the opinion of the Principal Investigator - Corneal dystrophies in either eye - Risk of visual field or visual acuity worsening as a consequence of participation in the study, in the investigator's best judgment - Bronchial hyper reactivity, or severe chronic obstructive pulmonary disease that would preclude the safe administration of a topical beta-blocker - History of severe allergic rhinitis - A condition, which in the opinion of the Principal Investigator, would interfere with optimal participation in the study, or which would present a special risk to the subject - Participation in any other investigational study within 30 days prior to the Screening Visit


NCT ID:

NCT01336569


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Fort Worth, Texas 76134
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.